Exact Mass: 413.1062

Exact Mass Matches: 413.1062

Found 37 metabolites which its exact mass value is equals to given mass value 413.1062, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

Methyl anhydroberberillate

Methyl anhydroberberillate

C21H19NO8 (413.1111)


   
   

Bicucullinine

Bicucullinine

C21H19NO8 (413.1111)


   

R306465

N-hydroxy-2-(4-(naphthalen-2-ylsulfonyl)piperazin-1-yl)pyrimidine-5-carboxamide

C19H19N5O4S (413.1158)


D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors

   

(Rp)-1-(1S)-[(2-Diphenylphosphino)ferrocenyl]ethanamine

(Rp)-1-(1S)-[(2-Diphenylphosphino)ferrocenyl]ethanamine

C24H24FeNP (413.0996)


   

NU7441(KU-57788)

8-(4-Dibenzothienyl)-2-(4-morpholinyl)-4H-1-benzopyran-4-one

C25H19NO3S (413.1086)


   

[7-(4-nitrooxybutoxy)-4-oxo-2-phenylchromen-5-yl] acetate

[7-(4-nitrooxybutoxy)-4-oxo-2-phenylchromen-5-yl] acetate

C21H19NO8 (413.1111)


   

FLUORESCENT YELLOW AA223

3-(5-(Aminosulfonyl)benzoxazol-2-yl)-7-(diethylamino)coumarin

C20H19N3O5S (413.1045)


   

Disperse Blue 148

Disperse Blue 148

C19H19N5O4S (413.1158)


   

N-(2-aminoethyl)ethane-1,2-diamine,2-(chloromethyl)oxirane,2-cyanoguanidine,sulfuric acid,hydrochloride

N-(2-aminoethyl)ethane-1,2-diamine,2-(chloromethyl)oxirane,2-cyanoguanidine,sulfuric acid,hydrochloride

C9H25Cl2N7O5S (413.1015)


   

6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]-quinoline hydrochloride

6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]-quinoline hydrochloride

C19H14ClF2N7 (413.0967)


   

(4-cyanobenzyl)triphenylphosphonium chloride

(4-cyanobenzyl)triphenylphosphonium chloride

C26H21ClNP (413.11)


   

2-(2,6-dichlorobenzyl)-6-phenyl-5-piperidino-3(2H)-pyridazinone

2-(2,6-dichlorobenzyl)-6-phenyl-5-piperidino-3(2H)-pyridazinone

C22H21Cl2N3O (413.1062)


   

4-({4-[(4-Aminobut-2-ynyl)oxy]phenyl}sulfonyl)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide

4-({4-[(4-Aminobut-2-ynyl)oxy]phenyl}sulfonyl)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide

C17H23N3O5S2 (413.1079)


   

N(6)-(dimethylallyl)adenosine 5-phosphate(2-)

N(6)-(dimethylallyl)adenosine 5-phosphate(2-)

C15H20N5O7P-2 (413.11)


   
   

(+)-Malbrancheamide C

(+)-Malbrancheamide C

C21H24BrN3O (413.1103)


   

acs.jmedchem.1c00409_ST.481

acs.jmedchem.1c00409_ST.481

C23H15N3O5 (413.1012)


   

N-(4-acetylphenyl)-2-[[1-(3,5-dimethoxyphenyl)-5-tetrazolyl]thio]acetamide

N-(4-acetylphenyl)-2-[[1-(3,5-dimethoxyphenyl)-5-tetrazolyl]thio]acetamide

C19H19N5O4S (413.1158)


   

(+)-Isomalbrancheamide C

(+)-Isomalbrancheamide C

C21H24BrN3O (413.1103)


   

4-hydroxy-N-[[2-oxo-1-(3-oxo-1H-isobenzofuran-1-yl)-3-indolylidene]amino]benzamide

4-hydroxy-N-[[2-oxo-1-(3-oxo-1H-isobenzofuran-1-yl)-3-indolylidene]amino]benzamide

C23H15N3O5 (413.1012)


   

2-[1-[[4-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-5,6-dimethyl-3H-thieno[2,3-d]pyrimidin-4-one

2-[1-[[4-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-5,6-dimethyl-3H-thieno[2,3-d]pyrimidin-4-one

C19H19N5O2S2 (413.098)


   

4-[[(5-Methyl-3-isoxazolyl)amino]methylidene]-2-[3-(trifluoromethyl)phenyl]isoquinoline-1,3-dione

4-[[(5-Methyl-3-isoxazolyl)amino]methylidene]-2-[3-(trifluoromethyl)phenyl]isoquinoline-1,3-dione

C21H14F3N3O3 (413.0987)


   

4-[(2E)-2-[1-[4-(Furan-2-ylmethylsulfamoyl)phenyl]ethylidene]hydrazinyl]benzoic acid

4-[(2E)-2-[1-[4-(Furan-2-ylmethylsulfamoyl)phenyl]ethylidene]hydrazinyl]benzoic acid

C20H19N3O5S (413.1045)


   
   

CBiPES (hydrochloride)

CBiPES (hydrochloride)

C21H20ClN3O2S (413.0965)


CBiPES hydrochloride is a mGlu2 receptor positive allosteric modulator (EC50: 92.8 nM). CBiPES hydrochloride attenuates stress-induced hyperthermia and PCP-induced hyperlocomotor activity. CBiPES hydrochloride can be used for research of neurological disease[1][2].

   

LUF6096

LUF6096

C22H21Cl2N3O (413.1062)


LUF6096, a potent allosteric enhancer of the adenosine A3 receptor, is able to allosterically enhance agonist binding. LUF6096 shows low orthosteric affinity for any of the adenosine receptors. LUF6096 shows protective effects in myocardial ischemia/reperfusion injury[1][2].

   

4-(4-hydroxyphenyl)-12-methyl-1,3-dioxo-2-oxa-7,12-diazatetraphene-8-carboximidic acid

4-(4-hydroxyphenyl)-12-methyl-1,3-dioxo-2-oxa-7,12-diazatetraphene-8-carboximidic acid

C23H15N3O5 (413.1012)


   

2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid

2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid

C21H19NO8 (413.1111)


   

4,5,7-trihydroxy-n-(1-methoxy-3-methyl-1-oxobutan-2-yl)-9,10-dioxoanthracene-2-carboximidic acid

4,5,7-trihydroxy-n-(1-methoxy-3-methyl-1-oxobutan-2-yl)-9,10-dioxoanthracene-2-carboximidic acid

C21H19NO8 (413.1111)


   

4,5,7-trihydroxy-n-[(2s)-1-methoxy-3-methyl-1-oxobutan-2-yl]-9,10-dioxoanthracene-2-carboximidic acid

4,5,7-trihydroxy-n-[(2s)-1-methoxy-3-methyl-1-oxobutan-2-yl]-9,10-dioxoanthracene-2-carboximidic acid

C21H19NO8 (413.1111)


   

(2s,3s)-2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid

(2s,3s)-2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid

C21H19NO8 (413.1111)


   

5-(2-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-2-oxoacetyl)-2h-1,3-benzodioxole-4-carboxylic acid

5-(2-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-2-oxoacetyl)-2h-1,3-benzodioxole-4-carboxylic acid

C21H19NO8 (413.1111)


   

(1s,13s,15s)-7-bromo-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15s)-7-bromo-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C21H24BrN3O (413.1103)


   

methyl 3,4-dimethoxy-2-{5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline-6-carbonyl}benzoate

methyl 3,4-dimethoxy-2-{5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline-6-carbonyl}benzoate

C21H19NO8 (413.1111)


   

(1s,13s,15s)-6-bromo-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15s)-6-bromo-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C21H24BrN3O (413.1103)